ANI Pharmaceuticals, Inc.
ANIP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $263 | $218 | $150 | $145 |
| Short-Term Investments | $0 | $6 | $5 | $6 |
| Receivables | $253 | $226 | $220 | $222 |
| Inventory | $146 | $138 | $137 | $137 |
| Other Curr. Assets | $37 | $15 | $23 | $18 |
| Total Curr. Assets | $698 | $603 | $536 | $528 |
| Property Plant & Equip (Net) | $64 | $59 | $58 | $57 |
| Goodwill | $62 | $61 | $61 | $60 |
| Intangibles | $500 | $520 | $538 | $542 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $71 | $92 | $88 | $85 |
| Other NC Assets | $12 | $8 | $10 | $12 |
| Total NC Assets | $710 | $740 | $756 | $756 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,408 | $1,343 | $1,292 | $1,284 |
| Liabilities | – | – | – | – |
| Payables | $70 | $55 | $53 | $46 |
| Short-Term Debt | $15 | $13 | $11 | $9 |
| Tax Payable | $9 | $3 | $14 | $7 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $176 | $166 | $123 | $132 |
| Total Curr. Liab. | $271 | $237 | $202 | $194 |
| LT Debt | $307 | $608 | $612 | $615 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $324 | $36 | $36 | $47 |
| Total NC Liab. | $632 | $645 | $647 | $661 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $902 | $881 | $849 | $855 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $25 | $25 | $25 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$51 | -$77 | -$85 | -$100 |
| AOCI | $3 | $3 | $4 | $5 |
| Other Equity | $554 | $510 | $500 | $499 |
| Total Equity | $506 | $462 | $443 | $429 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,408 | $1,343 | $1,292 | $1,284 |
| Net Debt | $60 | $404 | $473 | $479 |